Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease
Clinical trial NCT04346862 · UNKNOWN
Trial details
- NCT number
- NCT04346862
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-26
- Primary completion
- 2020-06-30
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.